Estimated projection of incidence and mortality of alcohol-related liver disease in China from 2022 to 2040: a modeling study.

Wu, Meiyu; Qin, Shuxia; Tan, Chongqing; Li, Sini; Xie, Ouyang; Wan, Xiaomin

Wu, Meiyu; Qin, Shuxia; Tan, Chongqing; Li, Sini; Xie, Ouyang; Wan, Xiaomin.

Afiliación

Wu M; Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, China.
Qin S; Institute of Clinical Pharmacy, Central South University, Changsha, 410011, Hunan, China.
Tan C; Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, China.
Li S; Institute of Clinical Pharmacy, Central South University, Changsha, 410011, Hunan, China.
Xie O; Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, China.
Wan X; Institute of Clinical Pharmacy, Central South University, Changsha, 410011, Hunan, China.

BMC Med ; 21(1): 277, 2023 07 27.

Article en En | MEDLINE | ID: mdl-37501074

Asunto(s)

Carcinoma Hepatocelular; Neoplasias Hepáticas; Humanos; Incidencia; Carcinoma Hepatocelular/epidemiología; Cirrosis Hepática/epidemiología; Consumo de Bebidas Alcohólicas/efectos adversos; Consumo de Bebidas Alcohólicas/epidemiología; Neoplasias Hepáticas/epidemiología

Palabras clave

Alcohol-related liver disease; Burden; China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudio: Incidence_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: BMC Med Asunto de la revista: MEDICINA Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google